Quarterly report pursuant to Section 13 or 15(d)

Stock Plans (Tables)

v3.21.2
Stock Plans (Tables)
9 Months Ended
Sep. 30, 2021
Schedule of Stock-based Compensation Expense

The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

$

4,264

 

 

$

2,308

 

 

$

14,014

 

 

$

3,203

 

Stock awards

 

 

 

 

 

43

 

 

 

19

 

 

 

152

 

Machine Box contingent common stock issuances

 

 

 

 

 

(37

)

 

 

 

 

 

(37

)

Performance-based stock options

 

 

 

 

 

1,996

 

 

 

16,314

 

 

 

5,917

 

Stock options

 

 

791

 

 

 

644

 

 

 

2,426

 

 

 

4,099

 

Employee stock purchase plan

 

 

86

 

 

 

157

 

 

 

337

 

 

 

364

 

Common stock issued for services

 

 

131

 

 

 

 

 

 

381

 

 

 

-

 

Total

 

$

5,272

 

 

$

5,111

 

 

$

33,491

 

 

$

13,698

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

$

226

 

 

$

278

 

 

$

1,358

 

 

$

654

 

Research and development

 

 

431

 

 

 

172

 

 

 

2,016

 

 

 

593

 

General and administrative

 

 

4,615

 

 

 

4,661

 

 

 

30,117

 

 

 

12,451

 

 

 

$

5,272

 

 

$

5,111

 

 

$

33,491

 

 

$

13,698

 

 

Schedule of Stock Award Activity

The Company’s stock award activity for the nine months ended September 30, 2021 was as follows:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2020

 

 

-

 

 

$

-

 

Granted

 

 

581

 

 

$

32.33

 

Forfeited

 

 

-

 

 

 

-

 

Vested

 

 

(581

)

 

$

32.33

 

Unvested at September 30, 2021

 

 

-

 

 

 

-

 

 

Schedule of Restricted Stock Unit Activity

The Company’s restricted stock unit activity for the nine months ended September 30, 2021 was as follows:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2020

 

 

829,124

 

 

$

11.53

 

Granted

 

 

448,020

 

 

$

41.31

 

Forfeited

 

 

(24,439

)

 

$

42.92

 

Vested

 

 

(749,374

)

 

$

10.77

 

Unvested at September 30, 2021

 

 

503,331

 

 

$

37.64

 

 

Schedule of Stock Option Activity

The activity during the nine months ended September 30, 2021 related to all other stock options was as follows:

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2020

 

 

5,400,070

 

 

$

12.60

 

 

 

 

 

Granted

 

 

298,455

 

 

$

28.69

 

 

 

 

 

Exercised

 

 

(488,636

)

 

$

9.69

 

 

 

 

 

Forfeited

 

 

(169,965

)

 

$

15.86

 

 

 

 

 

Expired

 

 

(3,579

)

 

$

6.45

 

 

 

 

 

Outstanding at September 30, 2021

 

 

5,036,345

 

 

$

13.73

 

 

6.33 years

 

$

52,783

 

Exercisable at September 30, 2021

 

 

4,114,851

 

 

$

13.74

 

 

5.82 years

 

$

41,747

 

 

Employee Stock Purchase Plan [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the nine months ended September 30, 2021 are set forth in the table below:

 

Expected term (in years)

 

0.5 - 2.0

 

Expected volatility

 

67% - 119%

 

Risk-free interest rate

 

 

0.1

%

Expected dividend yield

 

 

 

 

Stock Options [Member]  
Schedule of Fair Value Assumptions The following assumptions were used to compute the grant date fair values of the stock options granted during the nine months ended September 30, 2021:

 

Expected term (in years)

 

5.5 - 6.1

 

Expected volatility

 

80% - 83%

 

Risk-free interest rate

 

0.6% - 1.0%

 

Expected dividend yield

 

 

 

 

Performance-based Stock Options [Member]  
Schedule of Stock Option Activity

The activity during the nine months ended September 30, 2021 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows:

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2020

 

 

4,234,020

 

 

$

10.55

 

 

 

 

 

Exercised

 

 

(346,137

)

 

$

5.78

 

 

 

 

 

Forfeited

 

 

(12,552

)

 

$

5.92

 

 

 

 

 

Expired

 

 

(8,787

)

 

$

5.28

 

 

 

 

 

Outstanding at September 30, 2021

 

 

3,866,544

 

 

$

11.01

 

 

6.76 years

 

$

49,819

 

Exercisable at September 30, 2021

 

 

3,886,544

 

 

$

11.01

 

 

6.76 years

 

$

49,819